Vanguard Personalized Indexing Management’s Amicus Therapeutics FOLD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$535K	Buy	36,983 +12,822	+53%	+$184K	0.01%	1272
2025 Q4	$344K	Sell	24,161 -538	-2%	-$5.29K	﹤0.01%	1443
2025 Q3	$195K	Buy	24,699 +6,812	+38%	+$48.5K	﹤0.01%	1716
2025 Q2	$102K	Buy	17,887 +6,932	+63%	+$44.7K	﹤0.01%	1734
2025 Q1	$89.4K	Sell	10,955 -8,394	-43%	-$77.7K	﹤0.01%	1624
2024 Q4	$182K	Buy	19,349 +9,292	+92%	+$96.6K	﹤0.01%	1540
2024 Q3	$107K	Buy	+10,057	New	+$110K	﹤0.01%	1605
2023 Q4	–	Sell	-14,995	Closed	-$182K	–	1589
2023 Q3	$182K	Sell	14,995 -483	-3%	-$6.23K	0.01%	1319
2023 Q2	$194K	Buy	15,478 +1,716	+12%	+$20.4K	0.01%	1336
2023 Q1	$153K	Buy	13,762 +1,649	+14%	+$20.3K	0.01%	1364
2022 Q4	$148K	Buy	+12,113	New	+$136K	0.01%	1191

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Vanguard Personalized Indexing Management's FOLD Position: Q1 2026 in Review

Vanguard Personalized Indexing Management increased its Amicus Therapeutics (FOLD) stake by 53% in Q1 2026, buying an estimated $184K and bringing the position to 36,983 shares worth $535K. The position accounts for 0.01% of the portfolio, ranked #1272.

Vanguard Personalized Indexing Management first reported a position in FOLD in Q4 2022 and has held it in 11 quarters since. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Vanguard Personalized Indexing Management held 36,983 shares of Amicus Therapeutics worth $535K as of Q1 2026.
Vanguard Personalized Indexing Management bought 12,822 Amicus Therapeutics shares in Q1 2026, an estimated $184K.
Amicus Therapeutics made up 0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1272 holding.
Vanguard Personalized Indexing Management first reported a position in Amicus Therapeutics in Q4 2022 and has held it in 11 quarters since.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.